Close [X]
Companies & Industry »Company News
Lupin Ltd - Company News

BSE   23 Mar 17 | 11:30 AM

1476.50 9.7 (0.66%)
Mkt Price (Rs)   Chg Rs (Chg %)
Code: 500257
Face Value: 2

NSE   23 Mar 17 | 11:24 AM

1475.70 7.55 (0.51%)
Mkt Price (Rs)   Chg Rs (Chg %)
Code: LUPIN
Performance
1 Week : Rs 1,456.40 (1.38%)
1 Month : Rs 1,453.35 (1.59%)
1 Year : Rs 1,524.50 (-3.15%)
change companytradenow

  • 30 Nov 16
    08:15 AM
    Lupin is launching generic version of sleep disorder Nuvigil tablets in the US market. The brand has an annual market size of $515 million and Lupin is the third company to launch the generic version in the US.
  • 22 Nov 16
    08:34 AM
    Nifty continues its southbound journey as it breached below its psychological support. The sequence of the lower top lower bottom continued despite an oversold situation reported by the RSI.
  • 07 Nov 16
    09:29 AM
    Lupin has surged 8% to Rs 1,535 on BSE, erasing its entire previous weeks’ losses, after the drug maker on Saturday said that it has received Establishment Inspection Report (EIR) from the US health regulator for its Goa plant leading to closure of
  • 28 Sep 16
    12:50 AM
    Drug makers Lupin, Torrent and Cadila Healthcare are considering making bids to acquire Bayer’s dermatology business, valued $1 billion.
  • 24 Aug 16
    04:02 PM
    Drug major Lupin on Wednesday said its subsidiary Gavis Pharmaceuticals has received approval from the US health regulator to market generic linezolid tablets used for treating bacterial infection in the American market.
  • 17 Aug 16
    04:56 PM
    Drug firm Lupin on Wednesday said its subsidiary Gavis Pharmaceuticals has received final approval from the US health regulator to market potassium chloride extended release capsules, used for treating potassium deficiency in the bloodstream, in the
  • 09 Aug 16
    06:42 PM
    Drug maker Lupin recorded a net profit of Rs 881.9 crore in the first quarter of the financial year 2016-17 , up 55 per cent from Rs 568.5 crore during the same period last year.
    04:58 PM
    Lupin Ltd, India's third-largest drugmaker, posted a 55% rise in its first-quarter profit on Tuesday but its shares fell as some analysts noted the jump was driven in part by a lower tax rate.
    03:15 PM
    Lupin has dipped 5% to Rs 1,607, falling 7% from day’s high on the BSE, after the company reported Ebitda (earnings before interest, taxes, depreciation and amortisation) margin at 32.2% in June 2016 quarter against 32.8% in March 2016 quarter.
1|2|3|4|5|6|7|8|9|10|11|Next
Widgets Magazine

Sensex

Company Price Gain (%)
GAIL (India)376.702.10
Tata Motors467.851.73
Hero Motocorp3,358.001.43
NTPC162.951.40
Larsen & Toubro1,550.451.34
Widgets Magazine

Messages

Online Portfolio

You can create Online Portfolio here using the below button.

Widgets Magazine